开发双特异性抗体,驱动对类风湿关节炎相关抗原的选择性向局部补充抑制
Haiyu Wang1, Saskia Nugteren1, Rick J Groenland1
1Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
Annals of the rheumatic diseases
|July 19, 2025
概括
这项研究引入了两种特异性抗体 (bsAbs),这些抗体在局部抑制了类风湿性关节炎 (RA) 中的补充激活. 这些bsAbs向碳amylated蛋白质和招募补充调节器,为自身免疫性疾病提供一种新的局部治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 药物发现 药物发现 药物发现
背景情况:
- 类风湿性关节炎 (RA) 中的自身抗体激活补充,导致关节损伤.
- 系统补充抑制剂由于广泛的作用,具有感染等风险.
- 需要一种局部补充抑制的策略来保持系统性免疫力.
研究的目的:
- 设计双特异性抗体 (bsAbs) 用于针对RA的局部补充抑制.
- 将内源补充调节剂招募到疾病部位.
- 为了避免系统性免疫抑制,降低感染风险.
主要方法:
- 双特异性抗体 (bsAbs) 是通过受控的Fab-arm交换来设计的.
- 一个抗体臂向疾病抗原 (例如,碳amylated蛋白质);其他新兵补充调节者 (H因子或C4b结合蛋白).
- 测试了bsAbs的特异性,调节器招募和抑制补体激活.
主要成果:
- 抗碳amylated蛋白 (anti-CarP) bsAbs被成功生成,并显示了特定的结合.
- bsAbs有效地招募了H因子和C4b结合蛋白来准表面.
- bsAbs显著抑制了免疫复合体和RA患者自身抗体的补充激活.
结论:
- 双特异性抗体可以选择性地将血补充调节器招募到本地疾病部位.
- 这种方法可以实现有针对性的局部补充抑制,节省系统性免疫力.
- 这代表了针对RA等自身免疫性疾病的局部治疗的新治疗策略.
更多相关视频
10:19Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
Published on: May 12, 2023
1.3K
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
236
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
236
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cross-reactivity
31.5K
Overview
31.5K
Antibody Actions
1.4K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.4K
Special Features of Adaptive Immunity
1.1K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
1.1K
